SUMMIT THERAPEUTICS INC COM - Stock (SMMT)

CUSIP: 86627R102

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / Stock
Total 13F shares
2,680,373
Share change
+2,680,373
Total reported value
$33,209,000
Price per share
$12.39
Number of holders
7
Value change
+$33,209,000
Number of buys
7

Quarterly Holders Quick Answers

What is CUSIP 86627R102?
CUSIP 86627R102 identifies SMMT - SUMMIT THERAPEUTICS INC COM - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SUMMIT THERAPEUTICS INC COM - Stock (SMMT) as of Q1 2015

As of 31 Mar 2015, SUMMIT THERAPEUTICS INC COM - Stock (SMMT) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,680,373 shares. The largest 7 holders included LANSDOWNE PARTNERS (UK) LLP, Point72 Asset Management, L.P., AXA, SPHERA FUNDS MANAGEMENT LTD., First Eagle Investment Management, LLC, HENDERSON GROUP PLC, and Granite Point Capital Management, L.P.. This page lists 7 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.